Latest / Conversations in Lung Cancer Research
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
Editor's Note (June 2026): This episode was recorded prior to Australia's broad PBS listing of nivolumab and ipilimumab, which has removed the previous "once in a lifetime" restriction on immunotherapy. For the latest discussion on these changes and what they mean for lung cancer care, see our recent Conversations in Lung Cancer Research episodes on the broad immunotherapy listing.
---------------
Support TOGA
Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.
---------------
Connect with TOGA…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.